SCHEMBL3244933

SCHEMBL3244933

Oc1ccc2nc3c(O)cccc3nc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.71
KMT2A Q03164 3/20 0.71
MAPT P10636 2/20 0.71
RAB9A P51151 2/20 0.71
GAA P10253 1/20 0.71
NPSR1 Q6W5P4 1/20 0.71
ACHE P22303 1/20 0.67
NQO2 P16083 5/20 0.66
MYC P01106 1/20 0.44
MAX P61244 1/20 0.44
CYP1A2 P05177 1/20 0.42
MEN1 O00255 2/20 0.41
POLB P06746 1/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
CASP6 P55212 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
PIK3CG P48736 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3728001 1.00 ALDH1A1 (0.71) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL31011404 1.00 ALDH1A1 (0.71) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL345562 0.84 ALDH1A1 (1.00) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL3724665 0.82 KMT2A (0.67) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL20475248 0.82 MAPT (0.67) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL23612607 0.82 NQO2 (0.72) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL18387536 0.82 MAPT (0.67) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL20475366 0.82 NQO2 (0.72) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL23612603 0.82 MAPT (0.67) ALDH1A1KMT2AMAPTRAB9AGAA
SCHEMBL20475303 0.82 ALDH1A1 (0.95) ALDH1A1KMT2AMAPTRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118336061-A Aqueous organic flow battery of nitrosonaphthol metal complex 天津大学 2024-07-12 CN disclosed
EP-2210892-A2 Neurologically-active compounds Prana Biotechnology Limited (AU) 2010-07-28 EP disclosed
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2010-06-24 US disclosed
US-7692011-B2 8-hydroxy and 8-mercapto quinazolinones PRANA BIOTECHNOLOGY LIMITED (AU) 2010-04-06 US disclosed
EP-1558585-A4 NEUROLOGICALLY-ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LTD (AU) 2008-07-02 EP disclosed
US-20060167000-A1 Neurologically-active compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2006-07-27 US disclosed
EP-1558585-A1 NEUROLOGICALLY-ACTIVE COMPOUNDS Prana Biotechnology Ltd (AU) 2005-08-03 EP disclosed
WO-2004031161-A1 NEUROLOGICALLY-ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2004-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167000-A1 Neurologically-active compounds ACHE, PSEN1, PSEN2 ALDH1A1 634/4885KMT2A 2506/4885MAPT 5/4885
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS ACHE, PSEN1, PSEN2 ALDH1A1 703/4885KMT2A 2765/4885MAPT 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.